CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2020 Edition

CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2020 Edition



Summary



This report is the 10th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.



Scope



This report is required reading for –

– CMO executives who must have deep understanding of the injectables marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.



Reasons to Buy



– Overview of NDA drug approvals and the levels of outsourcing associated with NDA sub segments

– Detailed view of CDMO performance by number of approvals and an assessment of their sponsors market caps from Contract Service Providers database

– Outsourcing propensity for NMEs, different dosage forms and by sponsor company cap have all been assessed.

– Analysis of NME special products approvals such as those with Orphan, Breakthrough or Fast Track designations and assessment of outsourcing



Companies Mentioned:

Patheon NV

Catalent Inc

Vetter Pharma-Fertigung GmbH & Co KG

PCI Pharma Services

Baxter International Inc

Mylan NV

Pfizer Inc

Almac Group Ltd

Siegfried Holding AG

Ajinomoto Co Inc

Emergent BioSolutions Inc

Fareva SA

Aenova Holding GmbH

Alcami Corp

Renaissance Pharma Inc

Albany Molecular Research Inc

Fujifilm Corp

Jubilant Life Sciences Ltd

Recipharm AB

Boehringer Ingelheim International GmbH

Cenexi SAS

Delpharm SAS

Rottendorf Pharma GmbH

ACS Dobfar SpA

Fresenius Kabi AG

Hovione FarmaCiencia SA

Lonza Group Ltd

Gland Pharma Ltd

Takeda Pharmaceutical Co Ltd

Quotient Sciences Ltd

3M Drug Delivery Systems

Afton Scientific Corp

Cadila Healthcare Ltd

Cipla Ltd

Consort Medical Plc

Rentschler Biopharma SE

Johnson & Johnson

LTS Lohmann Therapie-Systeme AG

Merck & Co Inc

Mikart Inc

Cambrex Corp

Piramal Enterprises Ltd

Sanofi

Unither Pharmaceuticals

Adoh BV

ARx LLC

The Ritedose Corp

Akorn Inc

Alliance Contract Pharma LLC

Alvogen Inc

AstraZeneca Plc

Bausch Health Companies Inc

Bayer AG

Bristol-Myers Squibb Co

Cerovene Inc

Contract Pharmaceuticals Ltd

Galephar Pharmaceutical Research Inc

GlaxoSmithKline Plc

Grunenthal GmbH

Hikma Pharmaceuticals Plc

Instituto Bioclon

Klocke Pharma-Service GmbH

Importfab Inc

MIAS Pharma Ltd

NextPharma Technologies Holding Ltd

Nova Laboratories Ltd

Orion Corp

NMS Group SpA

Perrigo Co Plc

Pharmaceutics International Inc

Sanico NV

Sharp Packaging Services

Alpex Pharma SA

Exelead Inc

Sotera Health LLC

UPM Pharmaceuticals Inc

AbbVie Inc

Groupe Synerlab SAS

3SBio Inc

AlfaSigma SpA

Alkermes Plc

Aquestive Therapeutics Inc

ASM – Aerosol-Service AG

AustarPharma LLC

Avara Pharmaceutical Services Inc

Basic Pharma

Amgen Inc

Sintetica SA

Biogen Inc

BioRamo LLC

BSP Pharmaceuticals SpA

Centre for Probe Development and Commercialization

Therapure Biopharma Inc

Dexcel PT Holdings Ltd

DSM Pharmaceuticals Inc

Ei A Pharmaceutical SolutionWorks (TM)

Eisai Co Ltd

Dongbao Enterprise Group Co Ltd

Exela Pharma Sciences LLC

Famar Health Care Services

Ferndale Pharma Group Inc

Fritz Keller Holding AG

Gilead Sciences Inc

GBA Gesellschaft fur Bioanalytik mbh

Glatt GmbH

Glenmark Pharmaceuticals Ltd

Grifols SA

Torii Pharmaceutical Co Ltd

Holopack Verpackungstechnik GmbH

Institutt for Energiteknikk

Insud Pharma

Intas Pharmaceuticals Ltd

James Alexander Corp.

Kyowa Kirin Co Ltd

Lifecore Biomedical LLC

Laboratoires PANPHARMA SA

Laboratoires Pierre Fabre SA

Laboratorios Farmaceuticos Rovi SA

Les Laboratoires Servier SAS

Lyne Laboratories

Molteni Farmaceutici

Merck KGaA

Neolpharma SA De CV

Napp Pharmaceuticals Ltd

Nexgen Pharma Inc

Nordmark Arzneimittel GmbH & Co KG

Novast Holdings Ltd

OishiKoseido Corp

Stada Arzneimittel AG

Nordic Group BV

Novartis AG

Pharmaceutical Manufacturing Research Services Inc

Pharmascience Inc

Pharmasol Corp

Pierrel Spa

Pillar5 Pharma Inc

PARI Pharma GmbH

Porton Biopharma Ltd

Propak Health Ltd

PYRAMID Laboratories Inc

QPS Holdings LLC

R Pharm

Lyophilization Services of New England Inc

Evonik Industries AG

Rivopharm SA

Recro Pharma Inc

Sawai Pharmaceutical Co Ltd

Steri-Pharma LLC

Swedish Orphan Biovitrum AB

Tapemark Co

Teligent Inc

Adare Pharmaceuticals Inc

University of Iowa

Toyobo Co Ltd

Tris Pharma Inc

UCB SA

Vifor Pharma Ltd

USV Pvt Ltd

Vectura Group Plc

Vianex SA

Woodfield Pharmaceutical LLC

WuXi AppTec Co Ltd

Zymeworks Inc

Ritesh Tiwari is the Founder of Research By Markets. He has more than 7 years experience in the Market Research industry and a total experience spanning 18+ years. His core experience is in Sales and International Recruitments. Ritesh is a big foodie and a huge football fan, supporting Manchester United (EPL) and FC Barcelona (La Liga). He hardly misses watching any matches when these teams are playing. Get in touch with Ritesh via: enquiry@researchbymarkets.com *Industry Press Release is a part of Research By Markets.